Skip to main content
. 2015 Jun 17;89(17):8816–8827. doi: 10.1128/JVI.03737-14

TABLE 1.

Summary of IFA, Western blotting, ELISA, and HKU1 virus neutralization studies of mouse monoclonal antibodies to HKU1 S glycoprotein

Antibody and assay mHKUS-1 mHKUS-2 mHKUS-3 mHKUS-4 mHKUS-5 mHKUS-6
IFAa
    HKU1 S ++++ + ++ ++++ + +
    SARS S and infection
    MHV S and infection
    MERS S
    BCoV infection
    229E infection
    NL63 infection
Westernb
    S14-294aa ++++
    S295-755aa +
ELISAc
    HKU1 Secto ++++ ++++ ++++ ++++ ++++ ++++
    S14-755aa ++++ ++++ ++++ ++++ ++++ ++++
    S14-673aa ++++ ++++ ++++ ++++ ++++ ++++
    S14-534aa ++++
    S14-443aa ++++
    S14-294aa ++++
    S295-755aa + ++++ ++++ ++++ ++++ ++++
    S295-673aa + ++++ ++++ ++++ ++++ ++++
Neutralizationd ++++ ++++
a

For IFA, ++++ indicates that the percentage of virus antigen-positive cells was equal to or greater than 20%; +++, between 10 and 20%; ++, between 5 and 10%; +, between 1 and 5%; −, no positive cells. For HKU1 S, MHV S, SARS S, and MERS S infection, cells were transduced with plasmids encoding the membrane-anchored S proteins of these viruses. For SARS, MHV, BCoV, 229E, and NL63 infection, cells expressing the appropriate virus receptor proteins were infected with the indicated virus.

b

For Western blotting, ++++ indicates very strong signal; +++, strong signal; ++, weak signal; +, very weak signal; −, no signal.

c

For ELISA, ++++ indicates positive signal at 1:4,096 dilution of MAb or further; +++, positive signal at dilution between 1:256 and 1:4,096; ++, positive signal at dilution between 1:4 and 1:256; +, positive signal from undiluted or 1:4 dilution of hybridoma supernatant; −, no signal with undiluted hybridoma supernatant.

d

For neutralization, ++++ indicates greater than 100-fold inhibition of HKU1 virus infection, corresponding to the amount of viral RNA detected by real-time PCR in released virus at 48 hpi; +++, 10- to 100-fold inhibition; ++, 5- to 10-fold inhibition; +, 2- to 5-fold inhibition; −, no inhibition.

HHS Vulnerability Disclosure